IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD SLE
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD SLE
批准号:
6128376
负责人:
Morris Reichlin
金额:
$30.36万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-09-30 至 2005-03-31
关键词:
antibody formation apoptosis autoantibody binding proteins child (0-11) clinical research disease /disorder model human subject hybridomas immunopathology laboratory mouse longitudinal human study model design /development nephritis passive immunization protein biosynthesis ribosomal proteins systemic lupus erythematosus tissue /cell culture
中文摘要
描述:(改编自研究者摘要):儿童全身性
红斑狼疮(SLE)与成人疾病的不同之处在于
肾炎的发病率。研究人员假设,
肾炎的流行是由于几种类型的致肾炎自身抗体
与儿童期SLE同时发生。两个主要候选人
这些自身抗体是针对dsDNA的抗体,
被认为在成人狼疮肾炎和自身抗体中起作用,
核糖体“P”蛋白,以前没有报道,
患有狼疮性肾炎的人除了最近的初步调查
临床和动物数据支持抗P抗体在狼疮性肾炎中的作用,
已经发现抗dsDNA和抗核糖体“P”抗体都含有
在培养中直接结合和损伤细胞的亚群。根据
研究人员认为,这种抗体介导的体外细胞损伤现象可能是
它们在体内的免疫致病潜力的替代物。调查人员
建议定义个体中自身抗体的致病潜力
患者通过亲和纯化他们的自身抗体和研究他们的
与培养物中各种细胞类型的相互作用以及对细胞功能的影响
和生存能力。在初步研究中,他们复制了以前的工作,
显示一些人类抗dsDNA抗体通过补体损伤细胞,
依赖于细胞表面的机制,以及其他穿透细胞的机制,
定位于细胞核或细胞质,像抗P,
蛋白质合成研究人员将把这些免疫致病因素
体外性质与患者的临床状态。他们提议扩大
他们的研究独特型调节这些抗体的患者,
抗P抗体对成人的平行研究表明,与儿童一样,
抗dsDNA和抗P抗体的存在大大增加了
活动性肾炎调查人员还初步数据表明,抗P可能
在人肾小球洗脱液中富集,并建议扩大这些研究。
最后,他们建议开发一种动物模型来评估致肾炎性
诱导抗P抗体的可能性。他们希望这些研究能够
扩大对儿童肾炎免疫发病机制的看法,
成人SLE
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract): Childhood systemic
lupus erythematosus (SLE) differs from the disease in adults by a higher
prevalence of nephritis. The investigators hypothesize that this higher
prevalence of nephritis is due to several types of nephritogenic autoantibodies
that occur concurrently in the childhood form of SLE. Two major candidates for
these autoantibodies are those directed against dsDNA which have long been
recognized to play a role in adult lupus nephritis and autoantibodies to
ribosomal "P" protein which have not been reported previously to be associated
with either adult or pediatric lupus nephritis. Aside from recent preliminary
clinical and animal data that support a role for anti-P in lupus nephritis,
both anti-dsDNA and anti-ribosomal "P" antibodies have been found to contain
subsets that directly bind and injure cells in culture. According to the
investigators, this antibody-mediated, in vitro cell injury phenomenon could be
a surrogate for their immunopathogenic potential in vivo. The investigators
propose to define the pathogenic potential of the autoantibodies in individual
patients by affinity purifying their autoantibodies and by studying their
interaction with various cell types in culture and the effects on cell function
and viability. In preliminary studies, they have reproduced previous work by
showing that some human anti-dsDNA antibodies injure cells by a complement
dependent mechanism at the cell surface, and others penetrate the cell,
localize in either the nucleus or the cytoplasm, and like anti-P, inhibit
protein synthesis. The investigators will correlate these immunopathogenetic
properties in vitro with the patients' clinical status. They propose to expand
their studies of the idiotypic regulation of these antibodies in patients with
anti-P antibodies. Parallel studies in adults suggest that, like children, the
presence of both anti-dsDNA and anti-P antibodies greatly increase the risk of
active nephritis. The investigators also have preliminary data that anti-P may
be enriched in human glomerular eluates and propose to expand these studies.
Lastly, they propose to develop an animal model to assess the nephritogenic
potential of induced anti-P antibodies. They hope that these studies would
expand perspectives on the immunopathogenesis of nephritis in both children and
adults with SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sample Procurement and Management Core
-
批准号:7938657
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2009
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7673677
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2008
-
负责人:Morris Reichlin
-
依托单位:
Sample Procurement and Management Core
-
批准号:7325053
-
项目类别:
-
资助金额:$9.8万
-
财政年份:2007
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:7125194
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IRB Inovation at a Private Research Foundation
-
批准号:6591618
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : BONE DENSITY
-
批准号:6794414
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : IMMUN DIS
-
批准号:6794417
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
IMPROVEMENT OF BIOMEDICAL RESEARCH FACILITY
-
批准号:6541160
-
项目类别:
-
资助金额:$91.16万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : SLE
-
批准号:6794416
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6531904
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6793968
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : NERVOUS SYSTEM
-
批准号:6794418
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
BIOMED RES FACIL IMPROV : DIABETES
-
批准号:6794415
-
项目类别:
-
资助金额:$18.23万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6949730
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
Oklahoma Specialized Center of Research in SLE
-
批准号:6656256
-
项目类别:
-
资助金额:$115.5万
-
财政年份:2002
-
负责人:Morris Reichlin
-
依托单位:
PLANNING GRANT FOR A MULTIPURPOSE CLINICAL RES CENTER
-
批准号:6076195
-
项目类别:
-
资助金额:$16.15万
-
财政年份:1999
-
负责人:Morris Reichlin
-
依托单位:
REGULATION OF AUTOANTIBODIES TO RIBOSOMAL P PROTEINS
-
批准号:6170695
-
项目类别:
-
资助金额:$8.08万
-
财政年份:1998
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2083722
-
项目类别:
-
资助金额:$20.01万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2517517
-
项目类别:
-
资助金额:$21.27万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
IMMUNOLOGICAL MECHANISMS OF NEPHRITIS IN CHILDHOOD
-
批准号:2769639
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1995
-
负责人:Morris Reichlin
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: